Case studies
Recombinant Growth Factors: Key to the Biotech Future
A strategy to position biotechnological solutions in global markets.
Challenge
The demand for growth factors is booming, but the market faces high prices, limited accessibility, and reliance on a few players. Researchers have created an alternative with the potential to reduce costs and diversify applications. The challenge for Arvor was to analyze how this innovation could fit into sectors such as therapies, cosmetics, or food, and to define the best market entry strategy alongside an industrial scaling plan.
Solution
Arvor conducted an in-depth market study to map global demand for growth factors across various sectors. Competitors, entry barriers, and opportunities for differentiation were identified. Through expert interviews, priority applications were validated, and a roadmap was designed that includes pilots with industry partners, enabling progressive production scaling.
Result
The project delivered a clear market access strategy for growth factors, identifying high-potential sectors and strategic partners. A roadmap with validation and scaling phases was established, positioning the technology as a competitive alternative to established players.
“We designed the market access strategy for a new generation of recombinant growth factors, identifying priority applications and industrial scaling pathways.”
Success case studies in the sector Biotech
Case studies of Market analysis